Evaluating Collagen Cross-Linking (CCL) Treatment in Norway
Status:
Unknown status
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess safety, efficacy and stability of riboflavin-UV
induced cross-linking of corneal collagen in reducing the progression of keratecatasia and in
improving visual acuity. This is the first Norwegian study concerning CCL.